A comprehensive review from Cureus/PMC detailing the Child-Pugh , MELD , and FIB-4 scoring systems used for prognosis.
For those looking at future treatments, the FDA provides a draft on developing drugs for nonalcoholic steatohepatitis with compensated cirrhosis. Download from Regulations.gov (PDF) . Download cirrhose pdf
If you are drafting a medical report or reviewing a case, these calculations are the standard benchmarks: Components Primary Use Age, AST, ALT, Platelets Initial screening for fibrosis. Child-Pugh Bilirubin, Albumin, INR, Ascites, Encephalopathy Assessing 1–2 year survival. MELD Score Bilirubin, Creatinine, INR, Sodium Prioritizing liver transplant list. Sodium Prioritizing liver transplant list.